Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HDB✓SelectedUSD · HDBGSK vs HDB performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs HDB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
HDB return
-19.9%
Excess return
+62.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioHDBExcessAlpha
1D-2.3%-0.1%-2.2%-2.3%
7D-3.0%+1.1%-4.1%-3.2%
30D+0.4%+10.2%-9.8%-1.2%
3M-1.2%+13.4%-14.6%-3.3%
6M+0.9%+7.4%-6.5%-0.5%
YTD+4.0%-28.1%+32.1%+8.2%
1Y+7.3%-28.7%+36.0%+11.8%
3Y+57.1%-7.5%+64.6%+57.6%
5Y+43.0%-20.3%+63.3%+43.0%
All+43.0%-19.9%+62.9%+43.0%

Cumulative growth

Daily Returns

Daily percentage return beside HDB.

Daily Out/Under-Performance

Portfolio return minus HDB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HDB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded HDB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling